Tuberculosis and covid-19 co-infection in serbia: pandemic challenge in a low-burden country

HIGHLIGHTS

• who: Maja Stosic from the las Amu00e9ricas, Colombia University of Naples Federico II, Italy have published the research: Tuberculosis and COVID-19 co-infection in Serbia: Pandemic challenge in a low-burden country, in the Journal: (JOURNAL)
• what: Immunomodulatory treatment was applied in 23/53 (43.4%) patients; anticoagulation therapy in statistically significantly more cases in the study (35/53, 69.8%) than in 94/336 (27.9%) globally; and azithromycin in statistically significantly fewer cases (15/53, 28.3%) in the study compared to global (212/336, 63.1%).
• how: Data showed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.